Skip to content
The Peptide Field
Browse peptidesBlogFact checksCompare evidenceRead the sourcesSearch
Menu
SearchStart hereBrowse peptidesApproval and research checkerFact checksCompare evidenceRead the sourcesBlogAbout
Peptide legal status/LL-37

Legal status · Record reviewed August 30, 2026

Is LL-37 legal in the U.S.?

Short answer

LL-37 has no single legal status. It depends on the product and how it is supplied.

No FDA-approved U.S. LL-37 drug found; FDA plans an advisory-committee discussion before the end of February 2027. A research use only label does not make a product approved for people.

Pharmacy mixing (compounding): FDA had placed it in Category 2 for possible safety risks, and the request was then withdrawn (FDA page dated April 22, 2026).

Sports: we have no current sports-rule review for it yet.

Rules for buying, selling, and prescribing also depend on how a product is made and sold, and on state law.

This is not legal advice.

Whether you may buy, sell, or use a product also depends on pharmacy (compounding) rules, a prescription, and state law. Read how U.S. peptide law works.

Have a product in hand? Check if it is a prescription, compounded, or research-only product.

The three records behind this answer

Is there an FDA-approved LL-37 product?

No FDA-approved product

The record found no FDA-approved product. A label that says research use only does not make a product approved for people.

What the record says: No FDA-approved U.S. LL-37 drug found; FDA plans an advisory-committee discussion before the end of February 2027

Is it on FDA's compounding safety list?

Nomination withdrawn

Listed as cathelicidin LL-37.

FDA had placed it in Category 2 for possible safety risks. The person who asked FDA to allow it in compounding then withdrew the request. FDA still lists its safety concerns and has not made a final decision. A withdrawn request is neither a ban nor an approval.

Source: FDA's page of bulk drug substances that may present significant safety risks. FDA marks it current as of April 22, 2026. We checked it on October 15, 2026.

Do sports rules ban LL-37?

Not assessed

This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body.

Check the current World Anti-Doping Agency list and your sport's rules before you compete.

Other names in this record: LL37, Cathelicidin LL-37, Ropocamptide.

Go further

Read the full LL-37 record

What it is, what studies in people show, and what is still unknown.

Open the LL-37 record

Compare it with other peptides

See the FDA, compounding, and sports status of every peptide we reviewed in one table.

See all 34 peptides

Did this page answer your question?

Check if a vial is prescription, compounded, or research-onlyHow U.S. law treats peptidesSee every FDA-approved peptide productSports rules for LL-37

Allow optional site analytics and Google Analytics? We send general page categories and actions, never searches or form answers. No ads. Read the privacy policy.

The Peptide Field

This site explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.

Explore

What are peptides?Browse peptidesApproval and research checkerFact checksCompare evidenceBlog

Sources and updates

Read the sourcesHow fact checks workReview policyRecent reviewsReport a possible error
AboutPrivacy

© 2026 The Peptide Field